Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 4/20 | 0.31 |
| ▸ | RXRA | P19793 | 2/20 | 0.31 |
| ▸ | RARB | P10826 | 1/20 | 0.31 |
| ▸ | RARG | P13631 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.30 |
| ▸ | RXRB | P28702 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19845243 | 0.97 | PDK2 (0.31) | PDK2MTOR | |
| SCHEMBL19845281 | 0.96 | PDK2 (0.34) | PDK2RXRARARBRARGMTOR | |
| SCHEMBL25661470 | 0.96 | PDK2 (0.34) | PDK2RXRARARBRARGMTOR | |
| SCHEMBL25661608 | 0.96 | PDK2 (0.34) | PDK2RXRARARBRARGMTOR | |
| SCHEMBL25661503 | 0.96 | PDK2 (0.34) | PDK2RXRARARBRARGMTOR | |
| SCHEMBL19845286 | 0.96 | PDK2 (0.34) | PDK2RXRARARBRARGMTOR | |
| SCHEMBL25661516 | 0.96 | PDK2 (0.34) | PDK2RXRARARBRARGMTOR | |
| SCHEMBL25661687 | 0.96 | PDK2 (0.34) | PDK2RXRARARBRARGMTOR | |
| SCHEMBL19845241 | 0.95 | PDK2 (0.34) | PDK2RXRAMTORRXRB | |
| SCHEMBL19851401 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180037574-A1 | COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180037574-A1 | COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | PIEZO1, ETV6, LEF1 | PDK2 2616/4885RXRA 2893/4885RARB 3084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.